CASHMERE SRC140406-20Recalls & reported problems
Medos International Sàrl · CASHMERE microcoil CASHMERE 14 Stretch Resistant Coil 4mm x 6cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00878528004141), received between Feb 21, 2017 and Mar 23, 2023 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Stretched” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Stretched2
- Adverse Event Without Identified Device or Use Problem1
- Premature Separation1
- Separation Failure1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Aneurysm1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 23, 2023Separation Failure; Separation Failure
AS REPORTED BY THE FIELD, DURING A COIL EMBOLIZATION, A CASH 14 PLAT COIL 4MMX6CM COIL (SRC14040620, L15473) WOULD NOT DETACH DUE TO NO GREEN LIGHT ON THE DETACHMENT BOX. THE COIL WAS NOT CHECKED PRIOR TO THE USE OF THE COIL. THE COIL WAS REMOVED FROM THE ANEURYSM AND THE SAME MICROCATHETER, CONTROL CABLE AND BOX WERE USED IN THIS CASE. THIS WAS NOT THE FIRST COIL USED IN THE CASE AND THE OTHER COILS USED DETACHED WITHOUT ANY ISSUES. NO SIGNIFICANT DELAY IN TREATMENT. NO NEGATIVE IMPACT ON PATIENT CONDITION.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16599257 ↗MalfunctionFeb 21, 2023Stretched; Premature Separation; Stretched; Premature Separation
AS REPORTED BY THE FIELD, A CASH 14 PLAT COIL 4MMX6CM (SRC14040620, L15473) WAS ADVANCED THROUGH A HEADWAY DUO 156CM MICROCATHETER. THE COIL BECAME STRETCHED TO THE POINT THAT THE COIL WAS NOT PRESENT WHEN THE DELIVERY SYSTEM OF THE COIL WAS REMOVED FROM THE BODY. THE COIL WAS NOT LEFT INSIDE BODY. IT IS PRESUMED THAT IT IS STILL IN THE MICROCATHETER. THE HEADWAY WAS TAKEN OUT AND REPLACED WITH A DIFFERENT HEADWAY DUO. THE CASE WAS COMPLETED WITHOUT ISSUE WITH NEW MICROCATHETER.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16408078 ↗InjuryMay 18, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED BY THE STERLING STUDY, A (B)(6) FEMALE ((B)(6)) WITH A MEDICAL HISTORY OF CONTROLLED HYPERTENSION AND BEING A CURRENT SMOKER UNDERWENT COIL EMBOLIZATION OF A RIGHT UNRUPTURED SACCULAR ANEURYSM LOCATED IN THE ANTERIOR CIRCULATION, MIDDLE CEREBRAL ARTERY BIFURCATION ON (B)(6) 2020. MODIFIED RANKIN SCALE (MRS) SCORE WAS 0. PER IMMEDIATE PRE-PROCEDURE DIGITAL SUBTRACTION ANGIOGRAPHY PERFORMED ON (B)(6) 2020, THE ANEURYSM HAD THE FOLLOWING DIMENSIONS: HEIGHT 3.9MM, DOME 2.7MM, MAXIMUM ANEURYSM DIAMETER 5MM, NECK SIZE 2.2MM, AND DOME-TO-NECK RATIO 1.2MM. THE PARENT VESSEL DIAMETER WAS 3MM. THE FOLLOWING COILS WERE IMPLANTED VIA AN SL-10 (STRYKER) MICROCATHETER: ONE 4MM X 6MM CASHMERE 14 (MICRUS), ONE 3MM X 6MM GALAXY G3 MINI (GLM930060/K10497), ONE 2MM X 3CM GALAXY G3 MINI (GLM920030/30386750) AND ONE 2MM X 3CM GALAXY G3 MINI (GLM920030/L11009). THE PATIENT DID NOT EXPERIENCE ANY INTRA-OPERATIVE THROMBOEMBOLIC EVENTS. PACKING DENSITY WITHOUT G3 MINI COILS (USING ANGIOSUITE) WAS 20% AND AT THE CONCLUSION OF THE PROCEDURE (USING ANGIOSUITE) WAS 22%. IN THE OPINION OF THE INVESTIGATOR, THE TREATMENT OF THE TARGET ANEURYSM WAS CONSIDERED COMPLETE WITH NO DEVICE-RELATED SERIOUS AD
Patient problems: Aneurysm
MAUDE report 14427748 ↗MalfunctionFeb 21, 2017Stretched; Stretched
IT WAS REPORTED BY A HEALTHCARE PROFESSIONAL THAT THE CASHMERE COIL (SRC14040620/C24289) STRETCHED DURING USE. THERE WERE NO POTENTIAL ADVERSE EVENTS. THE PROCEDURE WAS COMPLETED WITH A SAME/LIKE PRODUCT, AND THERE WAS NO PROCEDURAL DELAY. IT WAS REPORTED THAT THE DEVICE WOULD BE RETURNED FOR ANALYSIS.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6345521 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page